OCT demonstrating neoatherosclerosis as part of the continuous process of coronary artery disease;OCT-Nachweis einer Neoatherosklerose als Teil des fortlaufenden Prozesses der koronaren Herzkrankheit

Herz

Volumn 40, Issue 6, 2015, Pages 845-854

  Zhang, B C ^a,b   Karanasos, A ^a   Regar, E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Bare metal stents; Drug eluting stents; Optical coherence tomography; Percutaneous coronary intervention

Indexed keywords

PACLITAXEL; RAPAMYCIN;

AGE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BARE METAL STENT; BIORESORBABLE SCAFFOLD; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DRUG ELUTING STENT; HUMAN; IN-STENT RESTENOSIS; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; PREVALENCE; PROSTHESIS FAILURE; RISK FACTOR; STENT THROMBOSIS; ADVERSE EFFECTS; ANIMAL; COMPUTER ASSISTED DIAGNOSIS; CORONARY BLOOD VESSEL; CORONARY RESTENOSIS; DISEASE COURSE; PATHOLOGY; PROCEDURES; STENT;

ANIMALS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; DISEASE PROGRESSION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; STENTS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84941996130     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-015-4343-y     Document Type: Article

References (67)

1. Daemen J, Wenaweser P, Tsuchida K et al (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369:667–678
2. Räber L, Magro M, Stefanini GG et al (2012) Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents a prospective cohort study. Circulation 125:1110–1121
3. Yamaji K, Kimura T, Morimoto T et al (2010) Very long-term (15–20 years) clinical and angiographic outcome after coronary bare metal stent implantation. Circ Cardiovasc Interv 3:468–475
4. Holmes DR Jr, Kereiakes DJ, Garg S et al (2010) Stent thrombosis. J Am Coll Cardiol 56:1357–1365
5. Windecker S, Meier B (2007) Late coronary stent thrombosis. Circulation 116:1952–1965
6. Nakazawa G, Otsuka F, Nakano M et al (2011) The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 57:1314–1322
7. Inoue K, Abe K, Ando K et al (2004) Pathological analyses of long-term intracoronary Palmaz-Schatz stenting; is its efficacy permanent? Cardiovasc Pathol 13:109–115
8. Ali ZA, Roleder T, Narula J et al (2013) Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents. Circ Cardiovasc Interv 6:507–517
9. Kang SJ, Mintz GS, Akasaka T et al (2011) Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 123:2954–2963
10. Muraoka Y, Sonoda S, Kashiyama K et al (2012) Evaluation of in-stent neointimal tissue components using integrated backscatter intravascular ultrasound: comparison of drug-eluting stents and bare-metal stents. Int J Cardiovasc Imaging 28:1635–1641
11. Yokoyama S, Takano M, Yamamoto M et al (2009) Extended follow-up by serial angioscopic observation for bare-metal stents in native coronary arteries: from healing response to atherosclerotic transformation of neointima. Circ Cardiovasc Interv 2:205–212
12. Tearney GJ, Regar E, Akasaka T et al (2012) Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 59:1058–1072
13. Karanasos A, Ligthart J, Witberg K et al (2012) Optical coherence tomography: potential clinical applications. Curr Cardiovasc Imaging Rep 5:206–220
14. Tanimoto S, Aoki J, Serruys PW et al (2006) Paclitaxel-eluting stent restenosis shows three-layer appearance by optical coherence tomography. EuroIntervention 1:484
15. Takano M, Yamamoto M, Inami S et al (2009) Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. J Am Coll Cardiol 55:26–32
16. Nakano M, Vorpahl M, Otsuka F et al (2012) Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging. JACC Cardiovasc Imaging 5:71–82
17. Karanasos A, Ligthart JM, Regar E (2012) In-stent neoatherosclerosis: a cause of late stent thrombosis in a patient with “full metal jacket” 15 years after implantation: insights from optical coherence tomography. JACC Cardiovasc Interv 5:799–800
18. Gonzalo N, Serruys PW, Okamura T et al (2009) Optical coherence tomography patterns of stent restenosis. Am Heart J 158:284–293
19. Nagai H, Ishibashi-Ueda H, Fujii K (2010) Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv 75:961–963
20. Tellez A, Afari ME, Buszman PP et al (2014) Peri-strut low-intensity areas in optical coherence tomography correlate with peri-strut inflammation and neointimal proliferation: an in-vivo correlation study in the familial hypercholesterolemic coronary swine model of in-stent restenosis. Coron Artery Dis 25:595–601
21. Kim JS, Afari ME, Ha J et al (2014) Neointimal patterns obtained by optical coherence tomography correlate with specific histological components and neointimal proliferation in a swine model of restenosis. Eur Heart J Cardiovasc Imaging 15:292–298
22. Kim JS, Hong MK, Shin DH et al (2012) Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT. JACC Cardiovasc Imaging 5:1147–1155
23. Kozuki A, Shinke T, Otake H et al (2013) Temporal course of vessel healing and neoatherosclerosis after DES implantation. JACC Cardiovasc Imaging 6:1121–1123
24. Van Soest G, Regar E, Goderie TP et al (2011) Pitfalls in plaque characterization by OCT: image artifacts in native coronary arteries. JACC Cardiovasc Imaging 4:810–813
25. Otsuka F, Byrne RA, Yahagi K et al (2015) Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J. pii: ehv205. 2015 May 20. [EPub ahead of print]
26. Hou J, Qi H, Zhang M et al (2010) Development of lipid-rich plaque inside bare metal stent: possible mechanism of late stent thrombosis? An optical coherence tomography study. Heart 96:1187–1190
27. Kitabata H, Loh JP, Pendyala LK et al (2014) Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound. Cardiovasc Revasc Med 15:149–155
28. Yonetsu T, Kato K, Kim SJ et al (2012) Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry. Circ Cardiovasc Imaging 5:660–666
29. Kang SJ, Song HG, Ahn JM et al (2012) OCT-verified neoatherosclerosis in BMS restenosis at 10 years. JACC Cardiovasc Imaging 5:1267–1268
30. Yonetsu T, Kim JS, Kato K et al (2012) Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am J Cardiol 110:933–939
31. Kim JS, Kim JS, Shin DH et al (2012) Optical coherence tomographic comparison of neointimal coverage between sirolimus- and resolute zotarolimus-eluting stents at 9 months after stent implantation. Int J Cardiovasc Imaging 28:1281–1287
32. Otsuka F, Vorpahl M, Nakano M et al (2014) Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation 129:211–223
33. Lee SY, Hur SH, Lee SG et al (2015) Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50 % neointimal area stenosis after second-generation drug-eluting stent implantation. Circ Cardiovasc Interv 8:e001878
34. Kuramitsu S, Sonoda S, Yokoi H et al (2014) Long-term coronary arterial response to biodegradable polymer biolimus-eluting stents in comparison with durable polymer sirolimus-eluting stents and bare-metal stents: five-year follow-up optical coherence tomography study. Atherosclerosis 237:23–29
35. Joner M, Nakazawa G, Finn AV et al (2008) Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 52:333–342
36. Tian F, Chen Y, Liu H et al (2014) Assessment of characteristics of neointimal hyperplasia after drug-eluting stent implantation in patients with diabetes mellitus: an optical coherence tomography analysis. Cardiology 128:34–40
37. Virmani R, Kolodgie FD, Burke AP et al (2005) Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25:2054–2061
38. Ino Y, Kubo T, Kitabata H et al (2013) Difference in neointimal appearance between early and late restenosis after sirolimus-eluting stent implantation assessed by optical coherence tomography. Coron Artery Dis 24:95–101
39. Kim BK, Kim JS, Shin DH et al (2012) Optical coherence tomography evaluation of in-stent restenotic lesions with visible microvessels. J Invasive Cardiol 24:116–120
40. Tian J, Ren X, Uemura S et al (2014) Spatial heterogeneity of neoatherosclerosis and its relationship with neovascularization and adjacent plaque characteristics: optical coherence tomography study. Am Heart J 167:884–892.e882
41. Kitabata H, Kubo T, Komukai K et al (2012) Effect of strut thickness on neointimal atherosclerotic change over an extended follow-up period (≥ 4 years) after bare-metal stent implantation: intracoronary optical coherence tomography examination. Am Heart J 163:608–616
42. Toutouzas K, Karanasos A, Stefanadis C (2013) Inflammatory mechanisms of adverse reactions to BMS. Curr Vasc Pharmacol 11:379–391
43. Park SJ, Kang SJ, Virmani R et al (2012) In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol 59:2051–2057
44. Vergallo R, Yonetsu T, Uemura S et al (2013) Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography. Am J Cardiol 112:1315–1321
45. Habara M, Terashima M, Nasu K et al (2013) Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study. Eur Heart J Cardiovasc Imaging 14:276–284
46. Farb A, Burke AP, Kolodgie FD et al (2003) Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108:1701–1706
47. Finn AV, Joner M, Nakazawa G et al (2007) Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115:2435–2441
48. Yamaji K, Inoue K, Nakahashi T et al (2012) Bare metal stent thrombosis and in-stent neoatherosclerosis. Circ Cardiovasc Interv 5:47–54
49. Karanasos A, Ligthart J, Witberg K et al (2013) Association of neointimal morphology by optical coherence tomography with rupture of neoatherosclerotic plaque very late after coronary stent implantation. In: Progress in Biomedical Optics and Imaging – Proceedings of SPIE. p 856542
50. Amabile N, Souteyrand G, Ghostine S et al (2014) Very late stent thrombosis related to incomplete neointimal coverage or neoatherosclerotic plaque rupture identified by optical coherence tomography imaging. Eur Heart J Cardiovasc Imaging 15:24–31
51. Amioka M, Shiode N, Kawase T et al (2014) Causes of very late stent thrombosis investigated using optical coherence tomography. Intern Med 53:2031–2039
52. Kang S-J, Lee CW, Song H et al (2013) OCT analysis in patients with very late stent thrombosis. JACC Cardiovasc Interv 6:695–703
53. Karanasos A, Witberg K, Van Geuns RJ et al (2012) Morphological characteristics by optical coherence tomography of ruptured neoatherosclerotic plaques in patients with very late stent thrombosis (abstract). Eur Heart J 33:176–176
54. Ko YG, Kim DM, Cho JM et al (2012) Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation. Int J Cardiovasc Imaging 28:715–723
55. Karanasos A, Witberg K, Ligthart J et al (2013) In-stent neoatherosclerosis: Are first generation drug eluting stents different than bare metal stents? An optical coherence tomography study. In: Progress in Biomedical Optics and Imaging – Proceedings of SPIE. p 856543
56. Karanasos A, Ligthart J, Schultz C et al (2012) Clinical and angiographic predictors of neointimal rupture as a culprit for very late stent thrombosis. Insights from optical coherence tomography (abstract). Eur Heart J 33:399–399
57. Karanasos A, Simsek C, Gnanadesigan M et al (2014) OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold. J Am Coll Cardiol 64:2343–2356
58. Karanasos A, Schuurbiers JC, Garcia-Garcia HM et al (2015) Association of wall shear stress with long-term vascular healing response following bioresorbable vascular scaffold implantation. Int J Cardiol 191:279–283
59. Karanasos A, Muramatsu T, Diletti R et al (2015) Early and late optical coherence tomography findings following everolimus-eluting bioresorbable vascular scaffold implantation in myocardial infarction: a preliminary report. Hellenic J Cardiol 56:125–135
60. Karanasos A, Van Mieghem N, Van Ditzhuijzen N et al (2015) Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience. Circ Cardiovasc Interv 8:e002369
61. Van Soest G, Goderie T, Regar E et al (2010) Atherosclerotic tissue characterization in vivo by optical coherence tomography attenuation imaging. J Biomed Opt 15:011105
62. Gnanadesigan M, Van Soest G, White S et al (2014) Effect of temperature and fixation on the optical properties of atherosclerotic tissue: a validation study of an ex-vivo whole heart cadaveric model. Biomed Opt Express 5:1038–1049
63. Regar E, Gnanadesigan M, Van Der Steen AF et al (2013) Quantitative optical coherence tomography tissue-type imaging for lipid-core plaque detection. JACC Cardiovasc Interv 6:891–892
64. Zahnd G, Karanasos A, Van Soest G et al (2015) Quantification of fibrous cap thickness in intracoronary optical coherence tomography with a contour segmentation method based on dynamic programming. Int J Comput Assist Radiol Surg. doi:10.1007/s11548-015-1164-7
65. Nadkarni SK, Pierce MC, Park BH et al (2007) Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography. J Am Coll Cardiol 49:1474–1481
66. Wang T, Wieser W, Springeling G et al (2013) Intravascular optical coherence tomography imaging at 3200 frames per second. Opt Lett 38:1715–1717
67. Alfonso F, Dutary J, Paulo M et al (2012) Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis. Heart 98:1213–1220